Utilizing co-culture models, we found that LDHC expression in breast cancer cells likely promotes an immunosuppressive tumor microenvironment, impairing immune cell function through alterations in cytokine secretion and modulation of immune checkpoint expression. The gene discussed is LDHC; the disease is neoplasm.